Login
Shopping Cart
Register
Home
|
Member Center
|
Sections
|
Practice Managers
|
Resources
|
RDDS
|
Tysabri® (natalizumab):
MEMBER CENTER
Join ASHP
Update Profile
Renew Membership
Members Only
Sections
Clinical Specialists and Scientists
Home, Ambulatory and Chronic Care Practitioners
Inpatient Care Practitioners
Pharmacy Informatics and Technology
Pharmacy Practice Managers
Webinars and Podcasts
Pharmacy Student Forum
New Practitioners Forum
Technicians
Member Magazine (InterSections)
Tysabri® (natalizumab): TOUCH Prescribing Program
Manufacturer’s Website
Prescribing Information
Package Insert and Letter
Patient Information
[PDF]
Program Information
TOUCH Validation System
FDA Summary of TOUCH
[PDF]
FDA Q&A
Other Resources
FDA: Drug Warning
[PDF]
FDA Summary on TYSABRI®
TYSABRI® (natalizumab) Risk Management Plan
[PDF]
Tysabri® Risk Minimization Action Plan (RiskMAP)
[PPT]
FDA News
National Multiple Sclerosis Society: Living with MS
Advertisement